| The LLDFVRFMGV peptide is derived from the Epstein-Barr virus nuclear antigen 6 (EBNA6), a protein expressed during the latent phase of EBV infection. EBNA6 plays a role in B-cell transformation and immortalization. Peptides from EBNA6 are utilized in research to study EBV latency and associated immune responses. Understanding T-cell responses to EBNA6-derived epitopes can provide insights into EBV-associated diseases and inform vaccine design. |
